Filtering by:
Cervical CancerCervical Precancers Drop Since Introduction of HPV Vaccine
A study using data from the Centers for Disease Control and Prevention (CDC) provides evidence that the human papillomavirus (HPV) vaccine is effectively reducing the numbers of cervical precancer – lesions that can become cervical cancer.
Studies Find Open Surgery Safer For Early Cervical Cancer
Researchers at the University of Texas MD Anderson Cancer Center and colleagues find that women who undergo minimally invasive radical hysterectomy to treat early-stage cervical cancer have worse outcomes than women who undergo abdominal “open” radical hysterectomy.
More Teens Getting HPV Vaccinations
The US Centers for Disease Control and Prevention (CDC) reports that almost half (49%) of teenagers have been fully vaccinated for human papillomavirus (HPV), an increase of 5 percentage points from 2016.
HPV Vaccination Rates Low Among Childhood Cancer Survivors
Despite the fact that the HPV vaccine is widely available and can help prevent forms of cancer caused by the virus, most young cancer survivors don’t get vaccinated.
FDA Approves a Biosimilar to Avastin for Cancer Treatment
The US Food and Drug Administration (FDA) has approved Mvasi (bevacizumab-awwb) as the first biosimilar drug for treating cancer. It works the same way as Avastin (bevacizumab).